SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001628280-23-031918 from Klaviyo, Inc. (KVYO) (CIK 0001835830) (KVYO)

Klaviyo, Inc. (KVYO) (CIK 0001835830)
Date: Sept. 11, 2023 · CIK: 0001835830 · Accession: 0001628280-23-031918

AI Filing Summary & Sentiment

File numbers found in text: 333-274211

Referenced dates: September 7, 2023

Date
September 11, 2023
Author
/s/ Bradley C. Weber
Form
CORRESP
Company
Klaviyo, Inc. (KVYO) (CIK 0001835830)

Letter

Document

Bradley C. Weber Goodwin Procter

+1 650 752 3226 601 Marshall Street

BWeber@goodwinlaw.com Redwood City, CA 94063

goodwinlaw.com

+1 650 752 3100

September 11, 2023

Securities and Exchange Commission

Division of Corporate Finance

100 F Street, N.E.

Washington, D.C. 20549

Attention: Austin Pattan

Jeff Kauten

Joseph Cascarano

Robert Littlepage

Re: Klaviyo, Inc.

Registration Statement on Form S-1

Filed August 25, 2023

File No. 333-274211

Ladies and Gentlemen:

This letter is submitted on behalf of Klaviyo, Inc. (the “Company”) in response to the comments of the staff of the Division of Corporation Finance (the “Staff”) of the Securities and Exchange Commission with respect to the Company’s Registration Statement on Form S-1 filed on August 25, 2023 (the “Registration Statement”), as set forth in the Staff’s letter dated September 7, 2023 addressed to Andrew Bialecki, Chief Executive Officer of the Company (the “Comment Letter”). The Company is concurrently filing an Amended Registration Statement on Form S-1 (the “Amended Registration Statement”), which includes changes that reflect responses to the Staff’s comments.

For reference purposes, the text of the Comment Letter has been reproduced herein with responses below each numbered comment. For your convenience, we have italicized the reproduced Staff comments from the Comment Letter. Unless otherwise indicated, page references in the descriptions of the Staff’s comments refer to the Registration Statement, and page references in the responses refer to the Amended Registration Statement. All capitalized terms used and not otherwise defined herein have the meanings set forth in the Amended Registration Statement.

The responses provided herein are based upon information provided to Goodwin Procter LLP by the Company.

Securities and Exchange Commission

September 11, 2023

Page 2

Registration Statement on Form S-1 filed August 25, 2023

Management's Discussion and Analysis of Financial Condition and Results of Operations

Overview, page 76

1. We note as of June 30, 2023 there is approximately $451.9 million of unrecognized stock-based compensation related to unvested restricted stock units subject to both a service-based vesting condition and a performance-based vesting condition. Please discuss, in quantified detail, the charge that will be incurred upon consummation of the offering. Also, please disclose the charge on page 104 and consider addressing this issue in your Risk Factor disclosures.

The Company respectfully acknowledges the Staff’s comment and advises the Staff that the Company has revised page 102 of the Amended Registration Statement to add quantification of the stock-based compensation amount to be incurred upon consummation of the offering. In addition, the Company has revised page 60 of the Risk Factors section of the Amended Registration Statement to address the Staff's comment.

Comparison of the Six Months Ended June 30, 2023 and 2022

Revenue, page 85

2. Please clarify the disclosure by briefly explaining why the dollar-based net retention rate, or NRR, is useful in understanding the usage growth of your services for all periods presented.

The Company respectfully acknowledges the Staff's comment and has removed this disclosure, as well as similar disclosure for the comparison of the years ended December 31, 2021 and 2022, from the Amended Registration Statement.

Unaudited Quarterly Results of Operations, page 90

3. Please revise the presentation of your financial statements and other data presented in tabular form so that it reads consistently from left to right in the same chronological order throughout the filing. In this regard, the presentation of your June 30, 2023 interim balance sheet alongside the December 31, 2021 year-end balance sheet should be addressed. We refer you to SAB Topic 11:E.

The Company respectfully acknowledges the Staff’s comment and advises the Staff that the Company considered SAB Topic 11:E in determining its presentation. The Company notes that SAB Topic 11:E does not specifically address the presentation of interim and annual periods alongside each other. The Company followed the convention of presenting the annual periods first, with the most current period first, and then the interim periods, with the most current period first, when reading left to right. The Company believes its approach is consistent with the intent of SAB Topic 11:E, as well as other similar filings as it has established a consistent presentation. The Company believes its presentation is clear to the reader when considering both annual and quarterly financial information are presented in one document and the presentation in its previously filed Form S-1 and S-1/A filings. This methodology has been consistently applied throughout the filing. The

Securities and Exchange Commission

September 11, 2023

Page 3

Company will ensure in future filings that financial statements and other data presented in tabular form will read consistently from left to right in the same chronological order throughout the filing per Staff Accounting Bulletin Topic 11:E.

Note 11. Stock-Based Compensation

Restricted Stock Units, page F-32

4. We note that you determined the weighted-average grant date fair value of the awards for the year ended December 31, 2023 to be $35.29 per RSU. We also note that RSUs granted during the quarter ended June 30, 2023 decreased to a weighted average grant date fair value of $23.45 per RSU. Please tell us and describe the factors that contributed to the differences in grant date fair values for these awards, including any intervening events within the company or changes in your valuation assumptions or methodology.

The Company respectfully acknowledges the Staff's comment and advises the Staff that based on common stock valuations performed during the six months ended June 30, 2023, the Company saw a decrease in the fair value of its common stock and redeemable common stock from the valuations performed during the year ended December 31, 2022. The Company further advises the Staff that this decrease was not due to a single business or economic event. Rather, the decrease was due to a change in overall market conditions arising from the macro-economic environment and the impact thereof on valuations of companies in the technology sector subsequent to the first quarter of fiscal year 2022. The Company has revised page 106 of the Amended Registration Statement to discuss the reason behind this decrease.

Signature Page Follows.

Securities and Exchange Commission

September 11, 2023

Page 4

We hope the foregoing answers are responsive to your comments. If you should have any questions concerning this correspondence, please contact the undersigned at (650) 752-3226.

Sincerely,
/s/ Bradley C. Weber

Show Raw Text
CORRESP
1
filename1.htm

Document

  Bradley C. Weber  Goodwin Procter

 +1 650 752 3226   601 Marshall Street

 BWeber@goodwinlaw.com  Redwood City, CA 94063

   goodwinlaw.com

   +1 650 752 3100

September 11, 2023

Securities and Exchange Commission

Division of Corporate Finance

100 F Street, N.E.

Washington, D.C.  20549

Attention: Austin Pattan

 Jeff Kauten

 Joseph Cascarano

 Robert Littlepage

Re:  Klaviyo, Inc.

  Registration Statement on Form S-1

  Filed August 25, 2023

  File No. 333-274211

Ladies and Gentlemen:

This letter is submitted on behalf of Klaviyo, Inc. (the “Company”) in response to the comments of the staff of the Division of Corporation Finance (the “Staff”) of the Securities and Exchange Commission with respect to the Company’s Registration Statement on Form S-1 filed on August 25, 2023 (the “Registration Statement”), as set forth in the Staff’s letter dated September 7, 2023 addressed to Andrew Bialecki, Chief Executive Officer of the Company (the “Comment Letter”).  The Company is concurrently filing an Amended Registration Statement on Form S-1 (the “Amended Registration Statement”), which includes changes that reflect responses to the Staff’s comments.

For reference purposes, the text of the Comment Letter has been reproduced herein with responses below each numbered comment.  For your convenience, we have italicized the reproduced Staff comments from the Comment Letter.  Unless otherwise indicated, page references in the descriptions of the Staff’s comments refer to the Registration Statement, and page references in the responses refer to the Amended Registration Statement.  All capitalized terms used and not otherwise defined herein have the meanings set forth in the Amended Registration Statement.

The responses provided herein are based upon information provided to Goodwin Procter LLP by the Company.

Securities and Exchange Commission

September 11, 2023

Page 2

Registration Statement on Form S-1 filed August 25, 2023

Management's Discussion and Analysis of Financial Condition and Results of Operations

Overview, page 76

1.    We note as of June 30, 2023 there is approximately $451.9 million of unrecognized stock-based compensation related to unvested restricted stock units subject to both a service-based vesting condition and a performance-based vesting condition. Please discuss, in quantified detail, the charge that will be incurred upon consummation of the offering. Also, please disclose the charge on page 104 and consider addressing this issue in your Risk Factor disclosures.

The Company respectfully acknowledges the Staff’s comment and advises the Staff that the Company has revised page 102 of the Amended Registration Statement to add quantification of the stock-based compensation amount to be incurred upon consummation of the offering. In addition, the Company has revised page 60 of the Risk Factors section of the Amended Registration Statement to address the Staff's comment.

Comparison of the Six Months Ended June 30, 2023 and 2022

Revenue, page 85

2.    Please clarify the disclosure by briefly explaining why the dollar-based net retention rate, or NRR, is useful in understanding the usage growth of your services for all periods presented.

The Company respectfully acknowledges the Staff's comment and has removed this disclosure, as well as similar disclosure for the comparison of the years ended December 31, 2021 and 2022, from the Amended Registration Statement.

Unaudited Quarterly Results of Operations, page 90

3.    Please revise the presentation of your financial statements and other data presented in tabular form so that it reads consistently from left to right in the same chronological order throughout the filing. In this regard, the presentation of your June 30, 2023 interim balance sheet alongside the December 31, 2021 year-end balance sheet should be addressed. We refer you to SAB Topic 11:E.

The Company respectfully acknowledges the Staff’s comment and advises the Staff that the Company considered SAB Topic 11:E in determining its presentation. The Company notes that SAB Topic 11:E does not specifically address the presentation of interim and annual periods alongside each other. The Company followed the convention of presenting the annual periods first, with the most current period first, and then the interim periods, with the most current period first, when reading left to right. The Company believes its approach is consistent with the intent of SAB Topic 11:E, as well as other similar filings as it has established a consistent presentation.  The Company believes its presentation is clear to the reader when considering both annual and quarterly financial information are presented in one document and the presentation in its previously filed Form S-1 and S-1/A filings. This methodology has been consistently applied throughout the filing. The

2

Securities and Exchange Commission

September 11, 2023

Page 3

Company will ensure in future filings that financial statements and other data presented in tabular form will read consistently from left to right in the same chronological order throughout the filing per Staff Accounting Bulletin Topic 11:E.

Note 11. Stock-Based Compensation

Restricted Stock Units, page F-32

4.    We note that you determined the weighted-average grant date fair value of the awards for the year ended December 31, 2023 to be $35.29 per RSU. We also note that RSUs granted during the quarter ended June 30, 2023 decreased to a weighted average grant date fair value of $23.45 per RSU. Please tell us and describe the factors that contributed to the differences in grant date fair values for these awards, including any intervening events within the company or changes in your valuation assumptions or methodology.

The Company respectfully acknowledges the Staff's comment and advises the Staff that based on common stock valuations performed during the six months ended June 30, 2023, the Company saw a decrease in the fair value of its common stock and redeemable common stock from the valuations performed during the year ended December 31, 2022. The Company further advises the Staff that this decrease was not due to a single business or economic event. Rather, the decrease was due to a change in overall market conditions arising from the macro-economic environment and the impact thereof on valuations of companies in the technology sector subsequent to the first quarter of fiscal year 2022.  The Company has revised page 106 of the Amended Registration Statement to discuss the reason behind this decrease.

Signature Page Follows.

3

Securities and Exchange Commission

September 11, 2023

Page 4

We hope the foregoing answers are responsive to your comments.  If you should have any questions concerning this correspondence, please contact the undersigned at (650) 752-3226.

Sincerely,

/s/ Bradley C. Weber

Bradley C. Weber

Goodwin Procter LLP

cc:  Andrew Bialecki, Klaviyo, Inc.

  Amanda Whalen, Klaviyo, Inc.

  Landon R. Edmond, Klaviyo, Inc.

  Cameron S. Vermette, Klaviyo, Inc.

  Craig M. Schmitz, Goodwin Procter LLP

  Kim S. de Glossop, Goodwin Procter LLP

  Kristin A. Gerber, Goodwin Procter LLP

  Frank F. Rahmani, Sidley Austin LLP

  Samir A. Gandhi, Sidley Austin LLP

  Helen Theung, Sidley Austin LLP

4